Wockhardt completes clinicaltest runs for anti-cancer drug
Wockhardt Ltd has completed clinical trial runs for its anti-cancer drug `erthropoetin,' which is expected to be launched in the Indian market by the year end.

Zydus Cadila Q1 net soars 102%; plans to beef up export operations
The Ahmedabad-based pharma major Zydus Cadila is actively looking to consolidate its operations in the high-margin export markets as part of its growth strategy.

Narayana Murthy is most-admired CEO, says poll
Infosys Technologies chairman NR Narayana Murthy has been voted India's most-admired CEO in the annual opinion poll conducted for Business Barons among CEOs and senior executives by Taylor Nelson Sofres Mode, the Indian affiliate of the world's second largest market research agency.


  Usha Beltron pact with IBM Global to set up B2B arm
  Cipla net vaults 21% to Rs 39 cr, sales rise 20%
  Ajanta Pharma net rockets to Rs 2.34 cr, applies for 11 patents
  Tata Chem incurs Rs 3.7cr loss, sales jump 18 per cent
  Cumi sells Vizagrefractory unit
  Kalyani Sharp to unveil home appliances range
  Clariant net spurts 12% to Rs 4 cr
  The index
  Ashok Leyland Fin net jumps 35% to Rs 20 cr
  Oberoi group sets sights on north, west for expansion
  Amara Raja Q1net down 5%to Rs 2.26 crore
  Bata second-quarter net profit dives to Rs 6.2 cr
  Torrent Pharma sales spurt 18% to Rs 93 cr
  Nicholas Piramal ties up with CBT to enter genome research
  Briefing
  Panel to study direct marketing plans of Reliance Petro, MRPL
  Essar Oil's Vadinar refinery achieves financial closure
  Glaxo first-half profit vaults 56.7 per cent to Rs 44 crore
  GM plans to enter small-car segment with 1000cc Corsa